IMPROVED OUTCOMES WITH AUTONOMIC MONITORING
About 5 million of the 18 million people with diabetes in the United States don’t even know they are diabetic!
Early detection and treatment of diabetes is important to keep people with diabetes healthy. It can be a major factor to help to reduce the risk of serious complications such as premature heart disease and stroke, blindness, limb amputations, and kidney failure.
Many people with Type 2 diabetes have no signs or symptoms but do have risk factors. Type 1 diabetes is typically detected much sooner than type 2, this is because the symptoms are dramatic and the need for medical intervention is immediate and obvious. While the signs and symptoms of type 2 diabetes can be absent or so mild that the disease may not be diagnosed for 7 to 10 years. This delay of diagnosis increases the risk for complications, such as nerve, eye, and kidney disease, when the disease is finally detected.
Early detection of diabetes and pre-diabetes is important so that a person can begin to manage the disease early and potentially prevent or delay the serious complications that can decrease the quality of life.
At Physio PS we recognize the importance of identifying the more than 5 million Americans with undiagnosed diabetes. Currently, people at risk for both Type 1 & 2, may have doctor perform various tests to track their glucose levels. These tests are often invasive and require lab work. Physio PS provides a person to be tested non-invasively with the highest quality of accurate data needed to determine diabetic and pre-diabetic states. The ability to track these proprietary quantifications allows for diagnosis long before the presents of symptoms, ensuring the ability to manage and treat the disease before symptomatic damage is done.
‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.